Notes on Efficient Remyelination Requires DNA Methylation (Adult OPCs)

DNA Methylation and Demethylation Enzymes in Remyelination

DNA methylation, a crucial epigenetic regulatory mechanism mediated by DNA methyltransferases (DNMTs), governs the differentiation of adult oligodendrocyte precursor cells (OPCs) during remyelination in the adult spinal cord. This process is vital for restoring myelin sheaths and axonal function following demyelination, holding potential therapeutic significance for neurological disorders such as Multiple Sclerosis (MS).

Key DNA Methyltransferases: DNMT1 and DNMT3A

1. DNMT1 (Maintenance Methyltransferase):

   • Primarily functions in maintaining established methylation patterns during DNA replication.
   • During early remyelination (around 5 days post-lesion, dpl), DNMT1 is highly expressed in NKX2.2+ OPCs (74.6 ± 5.3% at 5 dpl) and gradually declines by later stages (49.4 ± 4.0% at 21 dpl).
   • Its expression is significantly lower in mature CC1+ oligodendrocytes (OLs) (35.3 ± 6.3% at 5 dpl, decreasing to 9.2 ± 5.6% at 21 dpl).
   • In developmental myelination, DNMT1 is known to be essential for the transition from proliferating OPCs to differentiating OLs.

2. DNMT3A (De Novo Methyltransferase):

   • Responsible for establishing new methylation patterns on previously unmethylated DNA.
   • Exhibits a distinct expression pattern during remyelination: strong in CC1+ mature OLs, increasing from 81.0 ± 7.6% at 5 dpl to a peak of 97.8 ± 1.9% at 14 dpl, then decreasing to 74.0 ± 9.3% at 21 dpl within this population.
   • Conversely, its expression remains low in NKX2.2+ OPCs throughout remyelination (e.g., 17.4 ± 3.8% at 5 dpl, 6.7 ± 4.4% at 21 dpl).

These expression dynamics highlight an age-dependent division of labor, with DNMT1 being prominent in early adult OPCs and DNMT3A critical for later-stage differentiation of OLs.

Functional Roles and Consequences of DNMT Ablation

• Adult OPC Differentiation during Remyelination:

  • Ablation of Dnmt3a (single knockout) significantly impaired the differentiation of OPCs to mature OLs, as indicated by a reduced percentage of CC1+ OLs among OLIG2+ cells at 14 dpl (p < 0.05).
  • In contrast, Dnmt1 ablation alone did not produce a significant deficit in OL differentiation at 14 dpl in the adult remyelinating context.

• Overall Remyelination Outcome:

  • By 21 dpl, single knockouts of either Dnmt1 or Dnmt3a did not show major remyelination deficits compared to controls in terms of myelin thickness (g-ratio) or remyelination ranking.
  • However, dual ablation of both Dnmt1 and Dnmt3a resulted in significantly thinner myelin sheaths, indicated by higher g-ratios ($p \approx 0.0005$), and overall delayed remyelination compared to controls. The g-ratio is defined as the ratio of the inner axonal diameter to the outer diameter of the myelinated fiber: $g=\frac{d<em>{\text{inner}}}{d</em>{\text{outer}}}$. A lower g-ratio indicates thicker myelin.

• Compensatory Mechanisms and Epigenetic State:

  • In Dnmt3a ablated mutants, an increase in DNMT1 levels was observed in CC1+ cells, suggesting partial compensatory upregulation of DNMT1 when DNMT3A is absent. This compensation, however, is insufficient to fully restore remyelination when both enzymes are lost.
  • Global DNA methylation (5mC) levels in OLIG2+ cells increase during remyelination. In double Dnmt mutants, there was an increase in OLIG2+ cells with low 5mC and a decrease in medium-5mC OLIG2+ cells at 14 dpl, indicating alterations in the DNA methylation landscape consistent with impaired remyelination.

Therapeutic Implications

The distinct and age-dependent roles of DNMT1 and DNMT3A suggest that remyelination therapies may need to be tailored to the specific developmental stage or maturation status of the oligodendroglial population. Strategies targeting locus